98%
921
2 minutes
20
Background: There have been major advances in blood culture technology in the last decade, with both faster and more sensitive pathogen detection as well as more precise species identification. We have reassessed the results of positive blood cultures in this new clinical microbiology era with a focus on contaminant identification.
Methods: A retrospective study was conducted including all patients with a blood culture collected in 2 UMass Memorial Health emergency departments from September 2019 through April 2020. Contaminants were identified based on standard clinical microbiology laboratory criteria and independent retrospective review by 3 infectious disease (ID) physicians and an ID fellow.
Results: Of 5673 blood samples obtained, 5661 were analyzed after 12 were deemed inconclusive by the ID physician review. Blood culture contaminants accounted for 22.5% of the positive blood cultures. was the most frequent contaminant (33.4%), while was the most frequent pathogen (21%) causing true bacteremia. Coagulase-negative staphylococci remain the most frequent cause of blood culture contamination with being the most common. The species and were all determined to be contaminants in 100% of cases.
Conclusions: The improvements in clinical laboratory technology enable better discrimination of the relative pathogenicity of differing coagulase-negative staphylococci species.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12225663 | PMC |
http://dx.doi.org/10.1093/ofid/ofaf352 | DOI Listing |
Antimicrob Steward Healthc Epidemiol
September 2025
Emergency and Trauma Centre, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Objective: To determine the frequency and outcomes of early follow-up blood cultures (BCs) collected within 48 hours of patients being investigated for bacteremia in the emergency department (ED), as well as the number of new pathogens isolated.
Design: Retrospective observational study of patients who had BCs collected in the ED between October 2019 and July 2020.
Methods: This study was conducted in a large, metropolitan ED with annual census of over 82,000 adult presentations.
Appl Biosaf
August 2025
Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Background: Serum and other blood-derived products are widely used in biomedical and biopharmaceutical processes, especially for the production of vaccines or cell therapeutic applications. To ensure quality and safety, each serum lot undergoes testing for sterility to minimize the risk of disease transmission. A currently performed standard procedure is gamma-irradiation of serum for effectively killing pathogens.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
The Second Clinical College of Fujian Medical University, 362000 Quanzhou, Fujian, China.
Blood culture-negative infective endocarditis (BCNE) constitutes an important subtype of infective endocarditis. Despite the rarity of BCNE, this subtype poses a significant diagnostic challenge and promotes a high mortality rate. Recent advances in diagnostic modalities have facilitated the rapid identification of BCNE.
View Article and Find Full Text PDFVet Dermatol
September 2025
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USA.
Background: The antibacterial efficacy of chlorhexidine shampoo is directly affected by formulation and bathing factors.
Hypothesis/objective: To evaluate the in vitro antibacterial efficacy of chlorhexidine-containing shampoos at various dilutions and to compare their lathering ability.
Animals: No animals were utilised in this study.
Infect Control Hosp Epidemiol
September 2025
Washington University School of Medicine, Department of Medicine, St. Louis, MO, USA.
De-implementation of established practices is a common challenge in infection prevention and antimicrobial stewardship and a necessary part of the life cycle of healthcare quality improvement programs. Promoting de-implementation of ineffective antimicrobial use and increasingly of low-value diagnostic testing are cornerstones of stewardship practice. Principles of de-implementation science and the interplay of implementation and de-implementation are discussed in part I of this Society for Healthcare Epidemiology of America White Paper Series.
View Article and Find Full Text PDF